Lack of soluble tumor necrosis factor alpha receptor 1 and 2 and interleukin-1β compartmentalization in lungs of mice after a single intratracheal inoculation with live porphyromonas gingivalis

Experimental Lung Research

Volumn 35, Issue 7, 2009, Pages 605-620

  Nemec, Ana ^a   Pavlica, Zlatko ^a   Svete, Alenka Nemec ^a   Eržen, Damijan ^b   Crossley, David A ^a   Petelin, Milan ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

cytokines compartmentalization; local and systemic host response; mice; pneumonia; Porphyromonas gingivalis

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; UNCLASSIFIED DRUG; TNFRSF1A PROTEIN, MOUSE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPIRATION PNEUMONIA; BACTERIAL LOAD; BLOOD SAMPLING; CELL COMPARTMENTALIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOLOGY; IMMUNE RESPONSE; LUNG; MALE; MOUSE; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; SHAM PROCEDURE; ANIMAL; BACTERIAL COUNT; BACTERIAL PNEUMONIA; BACTEROIDACEAE INFECTION; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; SOLUBILITY;

ANIMALS; BACTEROIDACEAE INFECTIONS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; INTERLEUKIN-1BETA; INTERLEUKIN-6; LUNG; MALE; MICE; MICE, INBRED BALB C; PNEUMONIA, BACTERIAL; PORPHYROMONAS GINGIVALIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SOLUBILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75549084865     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140902783381     Document Type: Article

References (39)

1. Scannapieco FA: Role of oral bacteria in respiratory infection. J Periodontol. 1999;70:793-802.
2. Paju S, Scannapieco FA: Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 2007; 13: 508-512.
3. Huxley EJ, Viroslav J, Gray WR, Pierce AK: Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med. 1978;64:564-568.
4. Van Houte J, Green DB: Relationship between the concentration of bacteria in saliva and the colonization of teeth in humans. Infect Immun. 1974;9:624-630.
5. Hajishengallis G, Wang M, Bagby GJ, Nelson S: Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice. J Immunol. 2008;181:4141-4149.
6. Okuda K, Kimizuka R, Abe S, Kato T, Ishihara K: Involvement of periodontopathic anaerobes in aspiration pneumonia. J Periodontol. 2005;76:2154-2160.
7. Gendron R, Grenier D, Maheu-Robert L: The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect. 2000;2:897-906.
8. Terpenning MS, Taylor GW, Lopatin DE, Kerr CK, Dominguez BL, Loesche WJ: Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc. 2001;49:557-563.
9. Scannapieco FA: Systemic effects of periodontal diseases. Dent Clin North Am. 2005;49:533-550, vi.
10. Awano S, Ansai T, Takata Y, Soh I, Akifusa S, Hamasaki T, Yoshida A, Sonoki K, Fujisawa K, Takehara T: Oral health and mortality risk from pneumonia in the elderly. J Dent Res. 2008;87:334-339.
11. Kimizuka R, Kato T, Ishihara K, Okuda K: Mixed infections with Porphyromonas gingivalis and Treponema denticola cause excessive inflammatory responses in a mouse pneumonia model compared with monoinfections. Microbes Infect. 2003;5:1357-1362.
12. Petelin M, Naruishi K, Shiomi N, Mineshiba J, Arai H, Nishimura F, Takashiba S, Murayama Y: Systemic up-regulation of sTNFR2 and IL-6 in Porphyromonas gingivalis pneumonia in mice. Exp Mol Pathol. 2004;76:76-81.
13. Monton C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP: Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med. 1999;27:1745-1753.
14. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, SummerWR: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis. 1989;159:189-194.
15. Bauer TT, Ewig S, Filella X, Torres A: Comparison of the inflammatory response in ARDS and pneumonia: possible implication for the differential diagnosis. Intensivmedizin und Notfallmedizin 1999;36:702-708.
16. Igonin AA, Armstrong VW, Shipkova M, Lazareva NB, Kukes VG, Oellerich M: Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Clin Biochem. 2004;37:204-209.
17. Deng JC, Standiford TJ: The systemic response to lung infection. Clin Chest Med. 2005;26: 1-9.
18. Calbo E, Alsina M, Rodriguez-Carballeira M, Lite J, Garau J: Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone. Antimicrob Agents Chemother. 2008;52:2395-402.
19. Tutor JD, Mason CM, Dobard E, Beckerman RC, Summer WR, Nelson S: Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med. 1994;149:1107-1111.
20. Pavlica Z, Nemec A, Nemec A, Eržen D, Crossley DA, Petelin M: Local and systemic up-regulation of TNFa, IL-1β and IL-6 in mice intratracheally inoculated with Porphyromonas gingivalis. Acta Vet Brno. 2008;77:377-385.
21. Socransky SS, Haffajee AD: Microbiology of periodontal disease. In: Lindhe J, Karring T, Lang NP, eds. Clinical Periodontology and Implant Dentistry. Copenhagen: Munksgaard; 1997:138-188.
22. Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russell DA: Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine. 1995;7:26-38.
23. Mukhopadhyay S, Hoidal JR, Mukherjee TK: Role of TNFalpha in pulmonary pathophysiology. Respir Res. 2006;7:125.
24. Mizgerd JP, Skerrett SJ: Animal models of human pneumonia. Am J Physiol Lung Cell Mol Physiol. 2008;294:L387-L398.
25. Nelson S, Laughon BE, Summer WR, Eckhaus MA, Bartlett JG, Jakab GJ: Characterization of the pulmonary inflammatory response to an anaerobic bacterial challenge. Am Rev Respir Dis. 1986;133:212-217.
26. Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG: Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun. 1998;66:912-922.
27. Brieland JK, Jackson C, Menzel F, Loebenberg D, Cacciapuoti A, Halpern J, Hurst S, Muchamuel T, Debets R, Kastelein R, Churakova T, Abrams J, Hare R, O'Garra A: Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun. 2001;69:1554-1560.
28. McDuffie E, Obert L, Chupka J, Sigler R: Detection of cytokine protein expression in mouse lung homogenates using suspension bead array. J Inflamm (Lond). 2006;3:15.
29. O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF: Local inflammatory responses following bronchial endotoxin instillation in humans. Am J Respir Crit Care Med. 2001;163:1591-1598.
30. Perenboom RM, Beckers P, Van Der Meer JW, Van Schijndel AC, OyenWJ, Corstens FH, Sauerwein RW: Pro-inflammatory cytokines in lung and blood during steroid-induced Pneumocystis carinii pneumonia in rats. J Leukoc Biol. 1996;60:710-715.
31. Kurahashi K, Kajikawa O, Sawa T, Ohara M, Gropper MA, Frank DW, Martin TR, Wiener-Kronish JP: Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. J Clin Invest. 1999;104:743-750.
32. Karzai W, Cui X, Mehlhorn B, Straube E, Hartung T, Gerstenberger E, Banks SM, Natanson C, Reinhart K, Eichacker PQ: Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats. Anesthesiology. 2003;99:81-89.
33. Lamont RJ, Jenkinson HF: Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998;62:1244-1263.
34. Wolf HF, Rateitschak EM, Rateitschak KH, Hassel TM: Color Atlas of Dental Medicine. Periodontology. Stuttgart: Georg Thieme Verlag; 2005.
35. Neilson D, Kavanagh JP, Rao PN: Kinetics of circulating TNF-alpha and TNF soluble receptors following surgery in a clinical model of sepsis. Cytokine. 1996;8:938-943.
36. Ohe H, Takashiba S, Naruishi K, Chou HH, Yamada H, Nishimura F, Arai H, Murayama Y: Tumor necrosis factor-alpha (TNF-alpha)-induced and interleukin-1 beta (IL-1 beta)-induced shedding of TNF receptors from gingival fibroblasts. J Interferon Cytokine Res. 2000;20:1077-1082.
37. Xing Z, Gauldie J, Cox G, Baumann H, JordanaM, Lei XF, AchongMK: IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101:311-320.
38. Fox-Dewhurst R, Alberts MK, Kajikawa O, Caldwell E, Johnson MC 2nd, Skerrett SJ, Goodman RB, Ruzinski JT, Wong VA, Chi EY, Martin TR: Pulmonary and systemic inflammatory responses in rabbits with gram-negative pneumonia. Am J Respir Crit Care Med. 1997;155:2030-2040.
39. Gamble L, Bagby GJ, Quinton LJ, Happel KI, Mizgerd JP, Zhang P, Nelson S: The systemic and pulmonary lipopolysaccharide binding protein response to intratracheal lipopolysaccharide. Shock. 2009;3:212-217.